Filippo Crea/inocainternational.com
Aug 19, 2026, 18:51
Filippo Crea: AF and Alzheimer’s Disease – Does the Anticoagulant Choice Matter for the Brain?
Filippo Crea, Editor-in-Chief of European Heart Journal, shared a post on X about a recent article by Nanbo Zhu et al. published in European Heart Journal, adding:
“Atrial fibrillation and Alzheimer’s disease: does the anticoagulant choice matter for the brain?
Direct oral anticoagulants: slower cognitive decline than warfarin or no treatment.
Also fewer strokes, fewer deaths, no excess bleeding.
Read the Swedish nationwide study in EHJ.”
Title: Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer’s disease: a Swedish nationwide study
Authors: Nanbo Zhu, Hong Xu, Sara Garcia-Ptacek, Sumonto Mitra, Maria Eriksdotter
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 19, 2026, 19:09Gregory Lip: PFO Closure in Younger Patients With Cryptogenic Stroke
-
Aug 19, 2026, 18:42Alan Nurden: How Procoagulant Platelets Relate to Microparticle Release?
-
Aug 19, 2026, 18:25Ivan Centeno Sáenz: FeNO and Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
-
Aug 19, 2026, 18:10Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care and Access to Treatment in Fiji
-
Aug 19, 2026, 17:58Paulomi Ghosh: Delighted to Deliver a Talk on Hemostasis and Hemorrhage Control
-
Aug 19, 2026, 17:34Ryan O’Keefe: Clopidogrel Non-Responders and the Risk of Stent Thrombosis
-
Aug 19, 2026, 17:10Mavis Agnes Kisakye: Raising Awareness and Supporting Patients With Bleeding Disorders
-
Aug 19, 2026, 17:02Daniel Barsanow: ETHIZIA vs TachoSil for Hemostasis During Open Liver Surgery
-
Aug 19, 2026, 15:32Muhammad Abdullah: Comparing Oral Iron Treatments for Children With Anemia